- Published at
- by gurufocus.com
neutral
neutral
Valeo Pharma Inc (VPHIF) Q3 2024 Earnings Call Transcript Highlights: Revenue Decline and Strategic Restructuring
Revenue: $12.6 million for Q3 2024, down 11% from $14.1 million in Q3 2023.Year-to-Date Revenue: $40.3 million, nearly flat compared to $40.8 million for the s